30 March 2020 In line with the recommendation of the South African National Institute for Communicable Disease (NICD) and the recommendation of the World Health Organization (WHO), SAHPRA wishes to point out that the so-called Rapid test kits (serological test kits) that are being offered...
In line with the recommendation of the South African National Institute for Communicable Disease (NICD) and the recommendation of the World Health Organization (WHO), SAHPRA wishes to point out that the so-called Rapid test kits (serological test kits) that are being offered for the diagnosis...
The document in the link below has been prepared to serve as a guideline to healthcare professionals, reporting adverse drug reactions and product quality problems. It represents South African Health Products Regulatory Authority’s (SAHPRA’s) current thinking on the safety, quality and efficacy of medicines (including...
The World Health Organisation (WHO) has declared COVID-19 to be a Public Health Emergency of International Concern on 30 January 2020. On 14 March 2020, President Ramaphosa announced several steps to curb transmission and on 23 March 2020 further steps were announced. These steps reflect...
The South African Health Products Regulatory Authority (SAHPRA) has become aware of reports on social media, which raise questions about whether non-steroidal anti-inflammatory drugs (NSAIDS), such as ibuprofen, could worsen coronavirus disease (COVID-19) when used for the symptomatic treatment of pain and fever in patients...
The new coronavirus (COVID-19) will continue to have far-reaching consequences on public health as well as manufacturing and business in general across the globe. SAHPRA has put in place a series of initiatives aimed at minimising the potential negative impact of the pandemic on the...
SAHPRA represented at the Commission on Narcotic Drugs (CND) 63rd session in Vienna SAHPRA will be attending the United Nations Office on Drugs and Crime (UNODC) Commission on Narcotic Drugs (CND) 63rd session in Vienna from the 2 March 2020 to 6 March 2020. Ms...
SAHPRA- REVIEWING SCHEDULING STATUS OF CODEINE-CONTAINING MEDICINES The South African Health Products Regulatory Authority (SAHPRA) is reviewing the scheduling status of codeine following the growing use of the non-medicinal use of codeine-containing medicines. WHAT IS CODEINE? Codeine is classified as an opioid. Opioids are narcotics with a known...
Download PDF ...
